Rani Therapeutics Holdings, Inc. (RANI) Misses Q4 EPS by 1c

Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) reported Q4 EPS of ($0.27), $0.01 worse than the analyst estimate of ($0.26).

For earnings history and earnings-related data on Rani Therapeutics Holdings, Inc. (RANI) click here.

You May Also Be Interested In

• MScience Says Alphabet (GOOGL) Ad Growth Has Moderated in Sept
• B.Riley on New Era Energy & Digital (NUAI) AMid 31% Gain: 'We would be strong buyers on the back of this update'
• Evercore lifts Ciena rating on AI-driven optical networking boom